Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review

被引:1
作者
Zahir, Faryal [1 ]
Hanman, Alicia [1 ]
Yazdani, Nazmehr [1 ]
La Rosa, Sabrina [1 ]
Sleik, Gemma [1 ]
Sullivan, Brooke [1 ]
Mehdipour, Ava [1 ]
Malouka, Selina [1 ]
Kuspinar, Ayse [1 ]
机构
[1] McMaster Univ, Sch Rehabil Sci, 1400 Main St W,IAHS, Hamilton, ON L8S 1C7, Canada
关键词
Amyotrophic lateral sclerosis; Health-related quality of life; Quality of life; Psychometric properties; Interpretability; ASSESSMENT QUESTIONNAIRE ALSAQ-40; HEALTH-STATUS; SCORE RELIABILITY; NEURON DISEASE; RESPONSE RATE; SEIQOL-DW; VALIDATION; ALS; SCALE; INSTRUMENTS;
D O I
10.1007/s11136-023-03377-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeAmyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. There are many patient-reported outcome measures (PROMs) for measuring quality of life (QoL) and health-related QoL (HRQoL) within this population; however, there is limited consensus regarding which are most valid, reliable, responsive, and interpretable. This systematic review assesses the psychometric properties and interpretability of QoL and HRQoL PROMs for individuals with ALS.MethodsThis review was conducted following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) methodology for systematic reviews of PROMs. MEDLINE, EMBASE, and CINAHL databases were searched. Studies were included if their aim was to evaluate one or more psychometric properties or the interpretability of QoL or HRQoL PROMs in individuals with ALS.ResultsWe screened 2713 abstracts, reviewed 60 full-text articles, and included 37 articles. Fifteen PROMs were evaluated including generic HRQoL (e.g., SF-36), ALS-specific HRQoL (e.g., ALSAQ-40), and individualized QoL (e.g., SEIQoL) measures. Evidence for internal consistency and test-retest reliability were acceptable. For convergent validity, 84% of hypotheses were met. For known-groups validity, outcomes were able to distinguish between healthy cohorts and other conditions. Responsiveness results ranged from low to high correlations with other measures over 3-24 months. Evidence for content validity, structural validity, measurement error, and divergent validity was limited.ConclusionThis review identified evidence in support of the ALSAQ-40 or ALSAQ-5 for individuals with ALS. These findings can guide healthcare practitioners when selecting evidence-based QoL and HRQoL PROMs for patients and provide researchers with insight into gaps in the literature.
引用
收藏
页码:2447 / 2462
页数:16
相关论文
共 54 条
[1]   Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire [J].
Alankaya, Naile ;
Tulek, Zeliha ;
Ozakgul, Aylin ;
Kaya, Alper ;
Dik, Aynur .
JOURNAL OF NEUROSCIENCE NURSING, 2019, 51 (05) :253-258
[2]   Validation of quality of life instruments in ALS [J].
Bourke, SC ;
McColl, E ;
Shaw, PJ ;
Gibson, GJ .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 (01) :55-60
[3]   Comparison of instruments addressing quality of life in patients with ALS and their caregivers [J].
Bromberg, MB ;
Forshew, DA .
NEUROLOGY, 2002, 58 (02) :320-322
[4]   Assessing health status quality of life in ALS:: Comparison of the SIP/ALS-19 with the ALS functional rating scale and the short form-12 health survey™ [J].
Bromberg, MB ;
Anderson, F ;
Davidson, M ;
Miller, RG .
AMYOTROPHIC LATERAL SCLEROSIS, 2001, 2 (01) :31-37
[5]  
Brown RH, 2017, NEW ENGL J MED, V377, P162, DOI [10.1056/NEJMra1603471, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85]
[6]   Assessing individual quality of life in amyotrophic lateral sclerosis [J].
Clarke, S ;
Hickey, A ;
O'Boyle, C ;
Hardiman, O .
QUALITY OF LIFE RESEARCH, 2001, 10 (02) :149-158
[7]   Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies [J].
Damiano, AM ;
Patrick, DL ;
Guzman, GI ;
Gawel, MJ ;
Gelinas, DF ;
Natter, HM ;
Ingalls, KK .
MEDICAL CARE, 1999, 37 (01) :15-26
[8]   Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis [J].
De Marchi, Fabiola ;
Berry, James D. ;
Chan, James ;
Caldwell, Sarah ;
Ellrodt, Amy ;
Scalia, Jennifer ;
Burke, Katherine ;
Fang, Ton ;
Clark Sisodia, Rachel ;
Schwamm, Lee H. ;
Moura, Lidia M. V. R. ;
Paganoni, Sabrina .
JOURNAL OF NEUROLOGY, 2020, 267 (06) :1754-1759
[9]  
de Vet H.C. W., 2011, Measurement in Medicine: a practical guide, DOI DOI 10.1017/CBO9780511996214
[10]   Quality of life in amyotrophic lateral sclerosis/motor neuron disease: A structured review [J].
Epton, Joanna ;
Harris, Robert ;
Jenkinson, Crispin .
AMYOTROPHIC LATERAL SCLEROSIS, 2009, 10 (01) :15-26